Monitor Q2 2026 for actual delivery of $13M oral TPOXX to international customer; any delay or shortfall could further pressure the stock. The special dividend payout reduced cash reserves, leaving limited buffer for operations without new contracts.
SIGA drugs
SIGA drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 8 $4.80entry
- T+1 · 6mo ago −5.21%α −5.44% · $4.55
- T+5 · 6mo ago −11.25%α −12.71% · $4.26
- T+20 · 5mo ago −10.42%α −10.44% · $4.30
- T+60 · 3mo ago −32.50%α −37.34% · $3.24
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
SIGA reported Q1 2026 total revenues of $6.2M (down 11% YoY) and a net loss of $3.5M vs $0.4M loss a year ago, driven by a 40% decline in product sales. Forward guidance points to $13M oral TPOXX delivery in Q2 and $26M IV TPOXX by end of Q3, but the sharp earnings deterioration weighs on sentiment.
Key Financial Metrics
Key Facts
- Q1 2026 total revenues $6.2M vs $7.0M YoY (down 11%)
- Product sales $3.5M vs $5.8M YoY (down 40%)
- Net loss widened to $3.5M from $0.4M YoY
- Diluted loss per share $(0.05) vs $(0.01) YoY
- Expects $13M oral TPOXX delivery to Asia-Pacific customer in Q2 2026
- Expects $26M IV TPOXX delivery to US SNS by end of Q3 2026
- Paid special cash dividend of $0.60 per share on April 23, 2026
Financial Impact
Revenue decline of 11% YoY and net loss increase of $3.1M
Risk Factors
- Concentration on government and limited international contracts
- Declining product sales trend may continue without new orders
- Cash burn from operating losses and dividend reduces financial flexibility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3290508 |
Track record
6 reports on SIGA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $3.13 to $3.14 Now $2.85 +8.95% ▼ −0.32% +1.00% vs SPY
- Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $3.15 to $2.97 Now $2.85 −9.52% ▼ −5.71% −1.31% vs SPY
- Oct 28, 202619d ago Press Release Neutral 3/10 Entry $3.31 to $3.18 Now $2.85 −13.90% ▼ −3.93% −3.55% vs SPY
- May 8, 202627w ago DEFA14A Neutral 2/10 Entry $4.55 to $4.55 Now $2.85 −37.36% · 0.00% +0.14% vs SPY
- May 7, 202627w ago Press Release Bearish 6/10 Viewing Entry $4.80 to $4.55 Now $2.85 +40.63% ▲ +5.21% +5.44% vs SPY
- Mar 26, 202633w ago Press Release Neutral 4/10 Entry $4.69 to $4.65 Now $2.85 −39.21% ▼ −0.75% −0.40% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers